← Back to Clinical Trials
Recruiting NCT06440655

NCT06440655 The Efficacy and Safety of Platelet-rich Fibrin and Platelet Rich Plasma in Female Pattern Hair Loss Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06440655
Status Recruiting
Phase
Sponsor Siriraj Hospital
Condition Female Pattern Hair Loss
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2023-05-30
Primary Completion 2024-06-30

Trial Parameters

Condition Female Pattern Hair Loss
Sponsor Siriraj Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 10
Sex FEMALE
Min Age 20 Years
Max Age 55 Years
Start Date 2023-05-30
Completion 2024-06-30
Interventions
Platelet rich plasmaPlatelet rich fibrin

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The goal of this clinical trial is to compare between platelet-rich fibrin and platelet-rich plasma in female pattern hair loss . The main question\[s\] it aims to answer are: * efficacy between platelet-rich fibrin and platelet-rich plasma * safety between platelet-rich fibrin and platelet-rich plasma Participants will be divided into 2 side of treatment with composed of 1. Platelet rich plasma 2. Platelet rich fibrin

Eligibility Criteria

Inclusion Criteria: * Age 20-55 years * Female * Subject who was diagnosed with Female pattern hair loss in Ludwig Classification 2 (part width 2-4 centimeters) by Dermatologist Exclusion Criteria: * Pregnancy or Lactation subjects * Subject with history of platelet dysfunction, low platelet, anemia, cirrhosis, cancer, or immunocompromised host * Subject who are active smoking and alcoholism * Subject who has dermatitis, scar or infection at intervention area * Subject who has history of allergy to anesthesia drug * Subject who taking NSAIDs, Hormonal drug, anticoagulants drug * Subject who has psychiatric condition diagnosed by psychiatrist * Subject who are not allowed to take a photo

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology